Latest news with #Russell3000
Business Wire
an hour ago
- Business
- Business Wire
Palladyne AI Corp. to Join Russell 3000® and Russell 2000® Index
SALT LAKE CITY--(BUSINESS WIRE)-- Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) ('Palladyne AI'), a developer of artificial intelligence software for robotic platforms in the defense and commercial sectors, today announced that it has been added as a member of the broad-market Russell 3000 ® Index, effective after the U.S. market opens on June 30, 2025, as part of the 2025 Russell indexes reconstitution. 'We are extremely proud to be included in the Russell 3000 and 2000 Indexes this year,' said Ben Wolff, President and CEO, Palladyne AI. The annual reconstitution of the Russell U.S. indexes captures the 4,000 largest US stocks as of April 30, 2025, ranking them by total market capitalization. Membership in the Russell 3000Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index, as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes. 'We are extremely proud to be included in the Russell 3000 and 2000 Indexes this year,' said Ben Wolff, President and CEO, Palladyne AI. 'This is an important achievement for Palladyne AI as we expand our business and aim to impact a bigger investor pool, particularly reaching institutional investors.' For more information on the Russell 3000 Index and the Russell indexes reconstitution, visit the 'Russell Reconstitution' section on the FTSE Russell website. For more information on Palladyne AI and its artificial intelligence software for robotic platforms, please visit About Palladyne AI Corp. Palladyne AI Corp. (NASDAQ: PDYN) has developed an advanced artificial intelligence (AI) and machine learning (ML) software platform poised to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in a manner akin to human intelligence. Our AI and ML software platform empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. The Palladyne AI software solution operates on the edge and dramatically reduces the significant effort required to program and deploy robots enabling industrial robots and collaborative robots (cobots) to quickly achieve autonomous capabilities even in dynamic and or complex environments. Designed to achieve precise results with minimal training time, limited data sets, and lower power requirements, compared to current state-of-the-art solutions, Palladyne AI believes its software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing. Its applicability extends beyond traditional robotics to include Unmanned Aerial Vehicles (UAVs), Unmanned Ground Vehicles (UGVs), and Remotely Operated Vehicles (ROVs). Palladyne AI's approach is expected to elevate the return on investment associated with a diverse range of machines that are fixed, fly, float, or roll. By enabling autonomy, reducing programming complexity, and enhancing efficiency, Palladyne AI is paving the way for a future where machines can excel in tasks that were once considered beyond their reach.
Yahoo
2 hours ago
- Business
- Yahoo
U.S. Gold Corp. set to join Russell 3000® and Russell 2000® Indexes in FTSE Russell's Annual 2025 Reconstitution
CHEYENNE, Wyo., June 2, 2025 /PRNewswire/ -- U.S. Gold Corp. ("U.S. Gold," the "Company," "we," "our" or "us") (Nasdaq: USAU) is pleased to announce that we have met the criteria for inclusion in the broad-market Russell 3000 Index (the "Russell 3000") and the small-cap Russell 2000 Index (the "Russell 2000") at the conclusion of the Russell indexes annual reconstitution, effective after the U.S. market opens on June 30, 2025, according to a preliminary list of additions posted Friday, May 23, 2025. The reconstituted indexes are expected to take effect after U.S. market close on June 27, 2025, as part of the 2025 Russell Indexes reconstitution. Inclusion in the Russell 2000, which is maintained for one year, is based on inclusion in the broader Russell 3000. The Company's stock will also be automatically added to the appropriate growth and value indexes. The Russell 3000 includes the largest 3,000 U.S. public companies by market capitalization. The Russell 2000 is a subset of the Russell 3000 that is limited to small-cap companies. The indexes are reconstituted annually by re-ranking companies based on total market capitalization as of the reconstitution rank date, which was April 30, 2025, this year. Index membership results in automatic inclusion in the relevant growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. "We believe our preliminary inclusion in the Russell 3000 represents a significant validation of the momentum we're building at U.S. Gold," said Luke Norman, Chairman of U.S. Gold. "We're proud of our team's on-going commitment to developing the CK Gold Project in Cheyenne, WY and continuing to deliver value to our shareholders." Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell U.S. indexes, which belong to FTSE Russell, a prominent global index provider. For more information on the Russell 2000, Russell 3000 and the Russell indexes reconstitution, visit the "Russell Reconstitution" section on the FTSE Russell website. About U.S. Gold Corp. U.S. Gold Corp. is a publicly traded, U.S. focused gold and copper exploration and development company. U.S. Gold Corp. has a portfolio of exploration properties. Our CK Gold Project is located in Southeast Wyoming and has a Preliminary Feasibility Study technical report, which was completed by Samuel Engineering Inc. Our Keystone exploration property is on the Cortez Trend in Nevada. Our Challis Gold Project is located in Idaho. For more information about U.S. Gold Corp., please Cautionary Note Regarding Forward-Looking Statements Certain statements in this press release are forward-looking within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "proposed," "aims," "anticipates", "forecast," "estimated," "believes," "continues" and "intend," among others. These forward-looking statements include statements related to effective dates of (i) the Russell indexes reconstitution and (ii) our inclusion in the Russell 2000 and Russell 3000. The Company has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory, and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond the Company's control. The Company undertakes no duty to correct or update any information contained herein. For further informationU.S. Gold Relations+1 800 557 4550ir@ View original content: SOURCE U.S. Gold Corp.
Forbes
3 days ago
- Business
- Forbes
Noble Passes Through 8% Yield Mark
In trading on Friday, shares of Noble were yielding above the 8% mark based on its quarterly dividend (annualized to $2), with the stock changing hands as low as $24.60 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return. To illustrate, suppose for example you purchased shares of the iShares Russell 3000 ETF back on 5/31/2000 — you would have paid $78.27 per share. Fast forward to 5/31/2012 and each share was worth $77.79 on that date, a loss of $0.48 or 0.6% decrease over twelve years. But now consider that you collected a whopping $10.77 per share in dividends over the same period, increasing your return to 13.15%. Even with dividends reinvested, that only amounts to an average annual total return of about 1.0%; so by comparison collecting a yield above 8% would appear considerably attractive if that yield is sustainable. Noble is a member of the Russell 3000, giving it special status as one of the largest 3000 companies on the U.S. stock markets. 10 Stocks Where Yields Got More Juicy » In general, dividend amounts are not always predictable and tend to follow the ups and downs of profitability at each company. In the case of Noble, looking at the history chart for NE below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 8% annual yield. NE tickertech Other Top Dividends
Yahoo
4 days ago
- Business
- Yahoo
Top S&P 500 Opportunities: 3 Stocks with Significant Growth Potential
Palantir has some of the best growth opportunities of any S&P 500 company. Broadcom has a huge opportunity with custom artificial intelligence (AI) chips. AI inference could be a game changer for AMD. 10 stocks we like better than Palantir Technologies › The has a long track record of success despite most individual stocks underperforming. In fact, according to a J.P. Morgan study, between 1980 and 2020, two-thirds of stocks in the Russell 3000 index, which consists of the 3,000 largest U.S.-traded companies, underperformed the S&P 500 during that span, while 40% had negative returns. So what's the secret behind the S&P 500's success? One of the biggest factors behind its strong performance is that it is a market capitalization (market cap) index that lets its winners run. Ultimately, it is these megawinner growth companies that help power its returns. Let's look at three S&P 500 companies with significant growth potential. Added to the S&P 500 last year, Palantir Technologies (NASDAQ: PLTR) has some of the best growth potential of any company. The data gathering and analytics company saw strong, accelerating revenue growth over the past year, and both the U.S. government and commercial customers embrace its Artificial Intelligence Platform (AIP). While much of the focus on AI has been creating ever-better AI models, Palantir instead focused on the workflow and application software layers of AI to create an orchestration platform that can harness the power of AI models to help solve real-world problems. It does this by collecting data from disparate sources and structuring it into an "ontology" that then maps that data to real-world objects and processes. It has recently introduced AI agents within its platform that help automate decisions and drive action. Its solutions are being embraced across industries, including hospital operators, pipeline companies, insurance companies, and telecom companies. The breadth of problems to which Palantir's solutions can be applied is absolutely massive, and why the stock has the potential to eventually become a huge winner. The biggest risk to the stock fulfilling its potential is its high valuation and any impact on its business from reduced government spending. Previously a sleepy chip and networking giant, Broadcom (NASDAQ: AVGO) has some huge growth potential. The company's hardware and software businesses could both see some strong growth over the coming years. On the software side, Broadcom is looking to transform the business model of its recent acquisition, VMware. Since acquiring the virtualization and cloud computing solutions company in November 2023, it streamlined its operations and product solutions and began transitioning customers to a subscription model. The key for its software business moving forward is its VMware Cloud Foundation (VCF) platform, which lets customers manage workloads across public clouds and their own on-premise data centers. With enterprises starting to turn to AI hybrid solutions, Broadcom is nicely positioned to upsell its customers to VCF. On the hardware side, Broadcom makes components for a variety of markets, but its biggest opportunities are in networking and ASICs (application-specific integrated circuits). On the networking side, its components, such as Ethernet switches and network interface cards (NICs), are vital in managing the flow of data and distributing AI workloads across servers to make sure resources are being used best. However, it is the company's custom AI chip business that holds the most potential. Custom AI chips can outperform and use less power than mass-market graphics processing units (GPUs) for the specific tasks for which they are designed. Alphabet was its first customer, and its success has led to it winning additional customers. Broadcom sees a $60 billion to $90 billion serviceable market opportunity in its fiscal year 2027 (ending October 2027) with its three furthest-along customers; however, it has added more, including Apple. This is a huge opportunity for a company that generated $51.6 billion in revenue in fiscal year 2024. The biggest risk to the stock would be a slowdown in AI infrastructure spending. While a distant No. 2 player to Nvidia in the GPU market, Advanced Micro Devices (NASDAQ: AMD) has the potential to be another huge AI infrastructure winner. The company carved out a strong place in the data center market with its central processing units (CPUs), which act as the brain of a server, while GPUs provide the power. The market isn't as large as the GPU market, but it is still a big and growing one, and AMD has been taking market share. However, its biggest opportunity could be with AI inference. While Nvidia's GPUs have been the preferred chips to help train AI models, AMD has been able to carve out a nice niche in the inference space. On its last earnings call, AMD boasted that one of the largest AI model companies was now using its GPUs to process a significant percentage of its daily inference traffic. This is important because eventually, the AI inference market is expected to become much larger than the AI training market. With the company having established itself in this market and its GPUs much cheaper than those of Nvidia, it has a real opportunity to take some share in what could be a huge, growing market over the next few years. The biggest risk to AMD's stock would also be a slowdown in AI infrastructure spending, as well as it always being an afterthought to Nvidia. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,389!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $830,492!* Now, it's worth noting Stock Advisor's total average return is 982% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Geoffrey Seiler has positions in Alphabet. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Apple, Nvidia, and Palantir Technologies. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy. Top S&P 500 Opportunities: 3 Stocks with Significant Growth Potential was originally published by The Motley Fool
Miami Herald
4 days ago
- Business
- Miami Herald
Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes
TAMPA, FLORIDA / ACCESS Newswire / May 29, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take effect following the close of the U.S. equity market on Friday, June 27, 2025. The Russell 3000 Index encompasses the 3,000 largest U.S. companies by market capitalization, representing approximately 98% of the investable U.S. equity market. The Russell 2000 Index is a subset of the Russell 3000, measuring the performance of the small-cap segment. These indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. "Wellgistics Health's preliminary inclusion in the Russell 2000 and Russell 3000 indexes marks an important milestone in our company's journey," said Brian Norton, CEO of Wellgistics Health. "This recognition enhances our visibility among the broader investment community, supports increased institutional interest and ownership in our stock, and serves as strong validation of our team's ability to execute on our business plan and drive value to our shareholders." About Wellgistics Health Wellgistics Health, Inc. is a publicly traded healthcare infrastructure company redefining how medications move, are priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a nationwide network of over 6,000 independent pharmacies. Wellgistics Health provides real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment solutions, while equipping pharmacies with integrated financial, clinical, and digital tools. Its end-to-end platform supports a broad range of therapeutic areas from specialty-lite to chronic maintenance medications by eliminating friction, accelerating reimbursements, and enabling direct, transparent connections between manufacturers, providers, pharmacies, and patients. For more information, visit Forward-Looking Statements This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans, including without limitation its plan in connection with certain financings and cryptocurrencies and outlook and actions with respect to incurring future expenses. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at For more information, please contact: Media Contact: media@ Relations: investors@ Investor Relations Contact:Skyline Corporate Communications Group, LLCScott Powell, President1177 Avenue of the Americas, 5th FloorNew York, NY 10036Office: (646) 893-5835Email: info@ SOURCE: Wellgistics Health, Inc.
